|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:297-303
© 2007 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Department of Pediatrics, Division of Cardiology, Childrens Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa
b Department of Surgery, Division of Cardiothoracic Surgery, Childrens Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa
c Department of Anesthesiology and Critical Care Medicine, Childrens Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa
d Department of Pediatrics, Division of Cardiology, Childrens Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Received for publication February 1, 2007; accepted for publication February 21, 2007. * Address for reprints: Jean Ballweg, MD, Cardiac Intensive Care Unit, The Childrens Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19119. (Email: ballweg{at}email.chop.edu).
Objective: We compare the hemodynamics and perioperative course of shunt type in hypoplastic left heart syndrome at the time of stage 2 reconstruction and longer-term survival.
Methods: We retrospectively reviewed the echocardiograms, catheterizations, and hospital records of all patients who had a stage 1 reconstruction between January 2002 and May 2005 and performed a cross-sectional analysis of hospital survivors.
Results: One hundred seventy-six patients with hypoplastic left heart syndrome and variants underwent a stage 1 reconstruction with either a right ventricle–pulmonary artery conduit (n = 62) or a modified Blalock–Taussig shunt (n = 114). The median duration of follow-up is 29.1 months (range, 0-57 months). By means of Kaplan–Meier analysis, there is no difference in survival at 3 years (right ventricle–pulmonary artery conduit: 73% [95% confidence limit, 59%–83%] vs modified Blalock–Taussig shunt: 69% [95% confidence limit, 59%–77%]; P = .6). One hundred twenty-four patients have undergone stage 2 reconstruction (78 modified Blalock–Taussig shunts and 46 right ventricle–pulmonary artery conduits). At the time of the stage 2 reconstruction, patients with right ventricle–pulmonary artery conduits were younger (153 days [range, 108–340 days]; modified Blalock–Taussig shunt, 176 days [range, 80–318 days]; P = .03), had lower systemic oxygen saturation (73% [range, 58%–85%] vs 77% [range, 57%–89%], P < .01), and had higher preoperative hemoglobin levels (15.8 g/dL [range, 13–21 g/dL] vs 14.8 g/dL [range, 12–19 g/dL], P < .01) compared with those of the modified Blalock–Taussig shunt group. By means of echocardiographic evaluation, there was a higher incidence of qualitative ventricular dysfunction in patients with right ventricle–pulmonary artery conduits (14/46 [31%] vs 9/73 [12%], P = .02). However, no difference was observed in common atrial pressure or the arteriovenous oxygen difference.
Conclusion: Interim analyses suggest no advantage of one shunt type over another. This report raises concern of late ventricular dysfunction and outcome in patients with a right ventricle–pulmonary artery conduit.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |